BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Altor BioScience Corporation 

2810 North Commerce Parkway

Miramar  Florida  33025-3958  U.S.A.
Phone: 954-443-8600 Fax: 954-443-8610


SEARCH JOBS








 Company News
Altor BioScience Corporation Launches Its Proprietary IL-15 Superagonist ALT-803 Into Clinical Trials Against Cancer 8/15/2013 10:49:37 AM    More...
Altor BioScience Corporation and the Melanoma Research Alliance to Co-Support Clinical Studies of Altor’s Novel IL-15 Superagonist for Metastatic Melanoma 4/30/2012 10:25:23 AM    More...
Florida Biologix(R) Announces Manufacturing Agreement with Altor BioScience Corporation 6/28/2011 11:34:34 AM    More...
Altor BioScience Corporation Awarded $3 MM SBIR Phase II Competing Renewal Grant by NHBLI 5/23/2011 8:37:26 AM    More...
Altor BioScience Corporation Awarded $3 MM SBIR Bridge Grant by National Cancer Institute to Advance Clinical Trials for its Targeted Cancer Therapeutic ALT-801 9/25/2009 8:05:15 AM    More...
Altor BioScience Corporation Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital 9/10/2008 8:55:20 AM    More...
Altor BioScience Corporation In-Licenses Tissue Factor Antagonists from Genentech, Inc. (DNA) 2/12/2008 8:43:00 AM    More...
Altor BioScience Corporation Advances Clinical Trial for Targeted Cancer Therapeutic, ALT-801 12/20/2007 9:23:21 AM    More...
Altor BioScience Corporation Awarded Phase II SBIR Grant For Anti-Cancer Antibody Manufacture In Transgenic Plants 7/25/2006 10:21:00 AM    More...
Altor BioScience Corporation Introduces STAR(TM) Multimer Reagents To Measure Disease-Specific Antigen Presentation 3/13/2006 11:49:41 AM    More...
12

//-->